The Russian Direct Investment Fund (RDIF) has on Monday announced the approval of the Russian single-dose Sputnik Light COVID-19 vaccine by the Republic of the Congo’s health ministry.
Kirill Dmitriev, CEO RDIF said, “Republic of the Congo is widening the national coronavirus vaccine portfolio through authorization of Sputnik Light. The two-dose Sputnik V vaccine had already been approved in the country earlier this year.”
“We welcome the decision of the Ministry of Health enabling the Republic of the Congo to obtain access to safe, effective and affordable Sputnik Light vaccine.” Kirill added.
In March 2021, the two-dose Sputnik V vaccine was approved for use in the Republic of the Congo under the emergency use authorization procedure.
Sputnik V has thus far been authorized in 67 countries with total population of over 3.5 billion people.